Seattle biotech startup Bonum Therapeutics raised $93 million less than two months after its parent company Good Therapeutics was bought for $250 million by Roche, with the potential for milestone… Read More
Pharmaceutical giant Roche will acquire Good Therapeutics, reeling in its lead program six years after the Seattle startup was founded to design drugs that operate only where needed in the… Read More
The news: Seattle startup Good Therapeutics has raised $8 million to advance its therapeutic proteins designed to operate only where they are needed in the body. The platform: The company’s… Read More
Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act only when needed, raised $11 million in an equity round, according to a new SEC… Read More